BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) Short Interest Update

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) was the recipient of a large decline in short interest in August. As of August 14th, there was short interest totaling 83 shares, a decline of 91.7% from the July 30th total of 1,000 shares. Approximately 0.0% of the shares of the company are short sold. Based on an average daily volume of 14,615 shares, the days-to-cover ratio is currently 0.0 days.

BioForce Nanosciences Stock Performance

OTCMKTS BFNH traded down $0.01 during mid-day trading on Tuesday, reaching $3.89. 1,230 shares of the stock were exchanged, compared to its average volume of 6,659. The business’s 50 day moving average is $2.05 and its 200-day moving average is $1.16. BioForce Nanosciences has a 1 year low of $0.18 and a 1 year high of $4.20. The company has a market capitalization of $130.51 million, a P/E ratio of 389.39 and a beta of -0.52.

BioForce Nanosciences (OTCMKTS:BFNH) last released its quarterly earnings data on Monday, August 10th. The company reported $0.01 earnings per share for the quarter.

BioForce Nanosciences Company Profile

BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.